Edition:
India

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

303.75INR
3:48pm IST
Change (% chg)

Rs-2.80 (-0.91%)
Prev Close
Rs306.55
Open
Rs306.25
Day's High
Rs310.95
Day's Low
Rs303.00
Volume
54,738
Avg. Vol
261,868
52-wk High
Rs430.10
52-wk Low
Rs126.10

CLAI.BO

Chart for CLAI.BO

About

Claris Lifesciences Limited is a holding company. The Company is engaged in manufacturing of drugs and pharmaceutical products. The Company's geographical segments are India and Outside India. The Company's subsidiary, Claris Injectables Limited, is engaged in specialty Injectables business. The Company manufactures and markets... (more)

Overall

Beta: 1.10
Market Cap(Mil.): Rs16,727.75
Shares Outstanding(Mil.): 54.57
Dividend: 2.00
Yield (%): 0.65

Financials

  CLAI.BO Industry Sector
P/E (TTM): -- 29.51 30.38
EPS (TTM): -2.00 -- --
ROI: 5.65 15.44 14.86
ROE: -0.95 16.62 16.28

BRIEF-Claris Lifesciences seeks members' nod for sale/transfer of its injectables business

* Seeks members' nod for sale, transfer of 'injectables business' carried on by the company in India and overseas for $625 million Source text: http://bit.ly/2jF4Sd2 Further company coverage:

17 Jan 2017

BRIEF-Claris Lifesciences June-qtr consol profit up about 14 pct

* Consol net profit in june-quarter last year was 192.4 million rupees as per Ind-AS; consol gross sales from operations was 1.82 billion rupees Source text - (http://bit.ly/2bnoMod) Further company coverage:

19 Aug 2016

BUZZ-India's Claris Lifesciences hits near 14-mth high on FDA nod for injection

** Pharmaceutical company Claris Lifesciences Ltd's shares rise as much as 7.55 pct to their highest since May 27, 2015

26 Jul 2016

Earnings vs. Estimates